Scott Shuda - 18 May 2023 Form 4 Insider Report for InfuSystem Holdings, Inc (INFU)

Role
Director
Signature
/s/ Kevin R. Whitman, Attorney-in-Fact for Scott Shuda
Issuer symbol
INFU
Transactions as of
18 May 2023
Transactions value $
$0
Form type
4
Filing time
19 May 2023, 17:00:26 UTC
Previous filing
19 Sep 2022
Next filing
15 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding INFU Common Stock 340,624 18 May 2023 Footnote 1 F1
holding INFU Common Stock 90,494 18 May 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INFU Stock Options (right to buy) Award $0 +24,424 $0 24,424 18 May 2023 Common Stock 24,424 $9.18 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Mr. Shuda serves as Managing Director of (i) TSV Investment Partners, LLC, which is the sole general partner of Meridian OHC Partners, LP ("Meridian") and (ii) BlueLine Partners, LLC, which is the sole general partner of BlueLine Capital Partners II, LP ("BlueLine"). Accordingly, Mr. Shuda holds voting and dispositive power over the Common Stock held by Meridian and BlueLine. Mr. Shuda disclaims beneficial ownership for purposes of Rule 13d-3 with respect to the Common Stock held by Meridian and BlueLine.
F2 The option, representing the right to purchase a total of 24,424 shares of InfuSystem Holdings, Inc. common stock, vests on May 18, 2024.